78 related articles for article (PubMed ID: 21106380)
1. Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones.
Sorrentino F; Karioti A; Gratteri P; Rigobello MP; Scutari G; Messori L; Bindoli A; Chioccioli M; Gabbiani C; Bergonzi MC; Bilia AR
Bioorg Med Chem; 2011 Jan; 19(1):631-41. PubMed ID: 21106380
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
[TBL] [Abstract][Full Text] [Related]
3. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
Gorlatov SN; Stadtman TC
Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
[TBL] [Abstract][Full Text] [Related]
4. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial thioredoxin reductase purification, inhibitor studies, and role in cell signaling.
Rigobello MP; Bindoli A
Methods Enzymol; 2010; 474():109-22. PubMed ID: 20609907
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
9. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of thioredoxin reductase by lanthanum chloride.
Citta A; Folda A; Scutari G; Cesaro L; Bindoli A; Rigobello MP
J Inorg Biochem; 2012 Dec; 117():18-24. PubMed ID: 23078771
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
[TBL] [Abstract][Full Text] [Related]
12. On the potential of thioredoxin reductase inhibitors for cancer therapy.
Urig S; Becker K
Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro inhibition of mice thioredoxin reductase by methylmercury.
Wagner C; Sudati JH; Nogueira CW; Rocha JB
Biometals; 2010 Dec; 23(6):1171-7. PubMed ID: 20717703
[TBL] [Abstract][Full Text] [Related]
14. Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.
Casini A; Gabbiani C; Sorrentino F; Rigobello MP; Bindoli A; Geldbach TJ; Marrone A; Re N; Hartinger CG; Dyson PJ; Messori L
J Med Chem; 2008 Nov; 51(21):6773-81. PubMed ID: 18834187
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase.
Rigobello MP; Vianello F; Folda A; Roman C; Scutari G; Bindoli A
Biochem Biophys Res Commun; 2006 May; 343(3):873-8. PubMed ID: 16564501
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of Arabidopsis thaliana NADPH dependent thioredoxin reductase at 2.5 A resolution.
Dai S; Saarinen M; Ramaswamy S; Meyer Y; Jacquot JP; Eklund H
J Mol Biol; 1996 Dec; 264(5):1044-57. PubMed ID: 9000629
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin.
Qin H; Liang W; Xu Z; Ye F; Li X; Zhong L
Biochimie; 2015 Mar; 110():25-35. PubMed ID: 25576832
[TBL] [Abstract][Full Text] [Related]
19. Truncated mutants of human thioredoxin reductase 1 do not exhibit glutathione reductase activity.
Urig S; Lieske J; Fritz-Wolf K; Irmler A; Becker K
FEBS Lett; 2006 Jun; 580(15):3595-600. PubMed ID: 16750198
[TBL] [Abstract][Full Text] [Related]
20. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
Prast-Nielsen S; Cebula M; Pader I; Arnér ES
Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
